## **Core Concept**
Hand-foot syndrome, also known as palmar-plantar erythrodysesthesia, is a side effect associated with certain chemotherapeutic agents. It involves redness, swelling, and sometimes peeling of the skin on the palms of the hands and soles of the feet. This condition is related to the toxicity of specific drugs used in cancer treatment.

## **Why the Correct Answer is Right**
The correct answer, , is associated with hand-foot syndrome because it is a known side effect of this chemotherapeutic agent. works by inhibiting topoisomerase II, an enzyme critical for DNA replication, and is used in the treatment of various cancers. One of its notable side effects is hand-foot syndrome, which can be dose-limiting.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is not commonly associated with hand-foot syndrome as a primary side effect. Its side effects profile includes myelosuppression and alopecia but not typically hand-foot syndrome.
* **Option B:** is known for causing cardiotoxicity as a major side effect, rather than hand-foot syndrome.
* **Option C:** can cause various side effects, but hand-foot syndrome is not commonly highlighted among them.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that when administering , monitoring for signs of hand-foot syndrome is crucial, and dose adjustments may be necessary to mitigate this side effect. Early recognition and intervention can improve patient quality of life.

## **Correct Answer Line**
**Correct Answer: .**